Stanley Capital
menu
  • About Us
  • Team
  • ESG
  • Approach
  • Active Value Creation
  • Investments
  • News
NEWS

Portfolio and firm news

arrow down

Stanley Capital Summer 2022 Newsletter

Newsletter

Stanley Capital Spring 2022 Newsletter

Newsletter

Stanley Capital-backed portfolio company DSS acquires My Meds and Me

Press Release

Applied Artificial Intelligence Corporation and Stanley Capital Announce Partnership to Bring Artificial Intelligence to Private Equity Investments

Press Release

Stanley Capital Partners acquires Drug Safety Solutions from Astorg and Nordic Capital-backed Clario

Press Release

Grafine Partners and Stanley Capital Form Strategic Partnership to Invest in Growing Sustainable Businesses

Press Release

Healthcare AI Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering

Press Release

PDL BioPharma closes sale of Noden business to Stanley Capital

S&P Global

Stanley Capital Acquires Noden Pharma DAC

Wilkie Press Release

Noden Pharma DAC acquired by Stanley Capital

Press Release

PDL Biopharma Inc (PDLI) Q2 2020 Earnings Call Transcript

PDL Biopharma Q2 annoucement

Noden Pharma the right medicine in $48.25m deal

Independent

PDL BioPharma Enters Into Agreement for the Divestiture of the Noden Pharmaceutical Business to Stanley Capital

PR Newswire

Stanley Capital buys Irish pharma company with a view to consolidate the market

Private Equity News

Stanley Capital buys Irish pharma company with a view to consolidate the market

Private Equity News
Stanley Capital
© 2021 Stanley Capital Partners LLP

The contents of this website are communicated by, and the property of, Stanley Capital Partners LLP. Stanley Capital Partners LLP is an appointed representative of Umbra Capital Partners LLP which is authorised and regulated by the Financial Conduct Authority. This website is directed at persons who fall within the definition of ‘professional clients’ or ‘eligible counterparties’ as defined in the rules of the Financial Conduct Authority of the United Kingdom.

The information and opinions contained on this website are subject to updating and verification and may be subject to amendment. No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained on this website by Stanley Capital Partners LLP or its members. No liability is accepted by such persons for the accuracy or completeness of any information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained in this document.

The value of investments and any income generated may go down as well as up and is not guaranteed. Historical track record verified and audited. Past performance is not necessarily a guide to future performance.

Stanley Capital Partners LLP is incorporated in England and has registered number OC438675. Its registered office is at 5th Floor, 1 Old Queen Street, London, SW1H 9JA.

Terms of Use

CONTACT US

info@stanley-capital.com
  • linked-in
Joining Our Mailing List

Join our mailing list